IMPLEMENTATION OF A PILOT SCALE ANTICANCER DRUG SCREENING-PROGRAM UTILIZING DISEASE-ORIENTED PANELS OF HUMAN-TUMOR CELL-LINES

被引:0
|
作者
MONKS, A
SCUDIERO, D
SHOEMAKER, R
PAULL, K
FINE, D
MAYO, J
BOYD, M
机构
[1] NCI,FREDERICK CANC RES FACIL,PROGRAM RESOURCES INC,FREDERICK,MD 21701
[2] NCI,FREDERICK CANC RES FACIL,DEV THERAPEUT PROGRAM,FREDERICK,MD 21701
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:488 / 488
页数:1
相关论文
共 33 条
  • [21] DNA repair protein levels vis-a-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program
    Xu, ZY
    Chen, ZP
    Malapetsa, A
    Alaoui-Jamali, M
    Bergeron, J
    Monks, A
    Myers, TG
    Mohr, G
    Sausville, EA
    Scudiero, DA
    Aloyz, R
    Panasci, LC
    ANTI-CANCER DRUGS, 2002, 13 (05) : 511 - 519
  • [22] INVITRO CHEMOSENSITIVITY TESTING OF HUMAN NEUROBLASTOMA CELL-LINES IN SOFT AGAR - A TUMOR SPECIFIC DRUG SCREENING MODEL
    SAROSDY, MF
    SCHNEIDER, SL
    FORSETH, BJ
    ZELTZER, PM
    INVESTIGATIONAL NEW DRUGS, 1986, 4 (02) : 135 - 139
  • [23] DETOXIFICATION ABILITY AND TOXICITY OF QUINONES IN MOUSE AND HUMAN TUMOR-CELL LINES USED FOR ANTICANCER DRUG SCREENING
    DJURIC, Z
    CORBETT, TH
    VALERIOTE, FA
    HEILBRUN, LK
    BAKER, LH
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 36 (01) : 20 - 26
  • [24] SCREENING OF NEW ANTICANCER AGENTS INVITRO USING PANELS OF HUMAN CELL-LINES DERIVED FROM NONSEMINOMATOUS GERM-CELL TUMORS AND TRANSITIONAL CELL CARCINOMAS OF THE BLADDER
    MASTERS, JRW
    JENKINS, WEA
    SHOEMAKER, RH
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (10) : 1617 - 1622
  • [25] A COMPARATIVE-STUDY BETWEEN 2 [H-3] THYMIDINE RADIOLABEL PRECURSOR UPTAKE ASSAYS USING HUMAN-TUMOR CELL-LINES FOR THE EVALUATION OF NEW DRUG SCREENING
    FRIEDMAN, HM
    LOOMIS, L
    LANE, VG
    ZARCONE, D
    GLAUBIGER, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 420 - 420
  • [26] DIFFERENTIAL PATTERNS OF ANTI-TUMOR DRUG RESPONSES AND MECHANISMS OF RESISTANCE IN A SERIES OF INDEPENDENTLY-DERIVED VP-16-RESISTANT HUMAN-TUMOR CELL-LINES
    LOCK, RB
    HILL, BT
    INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (03) : 373 - 381
  • [27] HUMAN-TUMOR CELL-LINES WITH PLEIOTROPIC DRUG-RESISTANCE ARE EFFICIENTLY KILLED BY INTERLEUKIN-2 ACTIVATED KILLER-CELLS AND BY ACTIVATED MONOCYTES
    ALLAVENA, P
    GRANDI, M
    DINCALCI, M
    GERI, O
    GIULIANI, FC
    MANTOVANI, A
    INTERNATIONAL JOURNAL OF CANCER, 1987, 40 (01) : 104 - 107
  • [28] DIFFERENTIAL PATTERNS OF DRUG RESPONSES AND MECHANISMS OF RESISTANCE EXPRESSED IN 2 INDEPENDENTLY-DERIVED VP-16-RESISTANT HUMAN-TUMOR CELL-LINES
    LOCK, RB
    WHELAN, RDH
    HILL, BT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 294 - 294
  • [29] INHIBITION OF COLONY FORMATION OF DRUG-RESISTANT HUMAN-TUMOR CELL-LINES BY COMBINATIONS OF INTERLEUKIN-2-ACTIVATED KILLER CELLS AND ANTITUMOR DRUGS
    OHTSU, A
    SASAKI, Y
    TAMURA, T
    FUJIWARA, Y
    OHE, Y
    MINATO, K
    NAKAGAWA, K
    BUNGO, M
    SAIJO, N
    JAPANESE JOURNAL OF CANCER RESEARCH, 1989, 80 (03): : 265 - 270
  • [30] STRUCTURE AND FUNCTION OF HUMAN EFFUSION MACROPHAGES FROM PATIENTS WITH MALIGNANT AND BENIGN DISEASE .2. INVITRO CYTOSTATIC AND CYTOLYTIC EFFECT ON HUMAN-TUMOR CELL-LINES
    HAMMERSTROM, J
    ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA SECTION C-IMMUNOLOGY, 1980, 88 (04): : 201 - 209